Replies to post #22058 on Mymetics Corp (MYMX)

[bow-tie]

Leveraging the COVID-19 response to end preventable child deaths from pneumonia

Henrietta H Fore
UNICEF, New York, NY 10017, USA

Tedros Adhanom Ghebreyesus
World Health Organization, Geneva,

Kevin Watkins
Save the Children, London, UK

Leith Greenslade
Every Breath Counts Coalition, New York, NY, USA

Seth Berkley
Gavi, the Vaccine Alliance, Geneva, Switzerland

Quique Bassat
Barcelona Institute for Global Health, Barcelona, Spain

Philippe Duneton
Unitaid, Geneva,

Keith Klugman
Bill & Melinda Gates Foundation, Seattle, WA, USA

Alma Golden
United States Agency for International Development, Washington, DC, USA

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)32348-5/fulltext#%20

[bow-tie]

2010-05-14
Helmholtz Centre for Infection Research receives project funding from the Bill und Melinda Gates Foundation

Innovative nanoparticles release vaccine through perspiration
The novel concept in our method is the pathway through which the vaccine is administered. The nanoparticles penetrate via the hair follicles into the skin, then come into contact with human perspiration and release the active vaccine ingredients, mimicking what normally occurs during pollen sensitization. This method of vaccination by-passes the traditional and more painful needle-based vaccines and has the potential to stimulate mucosal immune responses.

https://www.helmholtz-hzi.de/en/news-events/news/view/article/complete/helmholtz-centre-for-infection-research-receives-project-funding-from-the-bill-und-melinda-gates-fou/